Q3 2025 Materialise NV Earnings Call Transcript
Key Points
- Materialise NV (MTLS) achieved double-digit growth in its medical unit, driven by advancements in the cardiac segment.
- The company released new versions of its cardiac and trauma planners, enhancing efficiency and accuracy for medical procedures.
- Materialise NV (MTLS) continues to make progress in its software segment with the launch of Magics SDKs and next-generation build processors.
- The company reported a strong gross profit margin of 56.8% for the third quarter of 2025.
- Materialise NV (MTLS) increased its net cash position to EUR67.7 million, supported by strong free cash flow.
- Overall revenue declined by 3.5% compared to the third quarter of 2024, impacted by macroeconomic headwinds.
- The Software and Manufacturing segments experienced revenue declines of 7% and 17%, respectively.
- The company's adjusted EBIT decreased to EUR2.9 million from EUR4.4 million in the same period of 2024.
- Materialise NV (MTLS) faced unfavorable foreign exchange effects, mainly due to a weaker US dollar.
- The Manufacturing segment reported a negative adjusted EBITDA of minus EUR0.8 million, reflecting ongoing challenges.
Good day, and welcome to the Q3 2025 Materialise financial results conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker, Ms. Harriet Fried with Alliance Advisors.
Thank you, everyone, for joining us today for Materialise's quarterly conference call. With us on the call are Brigitte de Vet, Chief Executive Officer; and Koen Berges, Chief Financial Officer. Today's call and webcast are being accompanied by a slide presentation that reviews Materialise's strategic, financial and operational performance for the third quarter of 2025. To access the slides, if you have not done so already, please go to the Investor Relations section of the company's website at www.materialise.com. The earnings release that was issued earlier today can also be found on that page.
Before we begin, I'd like to remind you that management may make
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
